| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:235.)
© 2006 American Heart Association, Inc.
Research Reports |
From the Experimental Cardiology Laboratory (J.P.G.S., W.P.C.P., A.H.S., E.V., C.F.S., D.P.V.d.K., G.P.) and Vascular Surgery (F.M.), University Medical Center, Utrecht; Interuniversity Cardiology Institute of the Netherlands (J.P.G.S., A.H.S., D.P.V.d.K.), Utrecht; Vascular Surgery (J.P.d.V.), Nieuwegein; and Biomedical Research (J.V., R.H.), The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands.
Correspondence to Gerard Pasterkamp, MD, PhD, University Medical Center, Experimental Cardiology Laboratory, Heidelberglaan 100, Room G02-523, 3584 CX Utrecht, the Netherlands. E-mail g.pasterkamp{at}hli.azu.nl
Background and Purpose We studied matrix metalloproteinases (MMP) 2, 8, and 9 and extracellular matrix metalloproteinase inducer (EMMPRIN) levels in relation to carotid atherosclerotic plaque characteristics.
Methods Carotid atherosclerotic plaques (n=150) were stained and analyzed for the presence of collagen, smooth muscle cell (SMC), and macrophages. Adjacent segments were used to isolate total protein to assess MMP-2 and MMP-9 activities and gelatin breakdown, MMP-8 activity, and EMMPRIN levels.
Results Macrophage-rich lesions revealed higher MMP-8 and MMP-9 activities, whereas SMC-rich lesions showed higher MMP-2 activity. The levels of less glycosylated EMMPRIN-45kD were higher in SMC-rich lesions and lower in macrophage-rich plaques. EMMPRIN-45kD was associated with MMP-2 levels, whereas EMMPRIN-58kD was related to MMP-9 levels.
Conclusions MMP-2, MMP-8, and MMP-9 activities differed among carotid plaque phenotypes. Different EMMPRIN glycosylation forms are associated with either MMP-2 or MMP-9 activity, which suggests that EMMPRIN glycosylation may play a role in MMP regulation and plaque destabilization.
Key Words: atherosclerosis carotid arteries carotid artery plaque endarterectomy inflammation matrix metalloproteinases
This article has been cited by other articles:
![]() |
Nitric Oxide Induces the Progression of Abdominal Aortic Aneurysms through the Matrix Metalloproteinase Inducer EMMPRIN Am. J. Pathol., October 1, 2009; 175(4): 1421 - 1430. |
||||
![]() |
M. G. Ionita, A. Vink, I. E. Dijke, J. D. Laman, W. Peeters, P. H. van der Kraak, F. L. Moll, J.-P. P.M. de Vries, G. Pasterkamp, and D. P.V. de Kleijn High Levels of Myeloid-Related Protein 14 in Human Atherosclerotic Plaques Correlate With the Characteristics of Rupture-Prone Lesions Arterioscler Thromb Vasc Biol, August 1, 2009; 29(8): 1220 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Goyette, W. X. Yan, E. Yamen, Y. M. Chung, S. Y. Lim, K. Hsu, F. Rahimi, N. Di Girolamo, C. Song, W. Jessup, et al. Pleiotropic Roles of S100A12 in Coronary Atherosclerotic Plaque Formation and Rupture J. Immunol., July 1, 2009; 183(1): 593 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T.G. Bot, I. E. Hoefer, J. P.G. Sluijter, P. van Vliet, A. M. Smits, F. Lebrin, F. Moll, J.-P. de Vries, P. Doevendans, J. J. Piek, et al. Increased Expression of the Transforming Growth Factor-{beta} Signaling Pathway, Endoglin, and Early Growth Response-1 in Stable Plaques Stroke, February 1, 2009; 40(2): 439 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Newby Metalloproteinase Expression in Monocytes and Macrophages and its Relationship to Atherosclerotic Plaque Instability Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2108 - 2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Welsh, P.H. Whincup, O. Papacosta, S.G. Wannamethee, L. Lennon, A. Thomson, A. Rumley, and G.D.O. Lowe Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men QJM, October 1, 2008; 101(10): 785 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Spinale Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function Physiol Rev, October 1, 2007; 87(4): 1285 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rodriguez-Feo, W. E. Hellings, B. A.N. Verhoeven, F. L. Moll, D. P.V. de Kleijn, J. Prendergast, Y. Gao, Y. van der Graaf, G. Tellides, W. C. Sessa, et al. Low Levels of Nogo-B in Human Carotid Atherosclerotic Plaques Are Associated With an Atheromatous Phenotype, Restenosis, and Stenosis Severity Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1354 - 1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Cummins, N. von Offenberg Sweeney, M. T. Killeen, Y. A. Birney, E. M. Redmond, and P. A. Cahill Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: a force to be reckoned with Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H28 - H42. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Waxman, F. Ishibashi, and J. E. Muller Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events Circulation, November 28, 2006; 114(22): 2390 - 2411. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |